Minimally invasive procedures such as endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) must yield not only good quality and quantity of material for morphological assessment, but also an adequate sample for analysis of molecular markers to guide patients to appropriate targeted therapies. In this context, cytopathologists worldwide should be familiar with minimum requirements for refereeing cytological samples for testing. The present manuscript is a review with comprehensive description of the content of the workshop entitled
especially respiratory samples. The workshop was designed to cover recent advances in molecular tests applied to cytological samples with the goal to improve the quality of specimens being obtained/received in their laboratories, to maximise the molecular and diagnostic yield.
The success of molecular analysis lies in good quality of the genetic material that can be obtained from smears, cytospin preparations (CP), LBC and cell blocks (CBs). Each of these preparations has advantages and drawbacks in terms of efficacy, costs, standardisation and infrastructure requirements. A summary of the technical procedures applied to various types of collecting medium and cytology preparations for molecular analysis are depicted in Figure 1 . The structure of this review includes those cytology substrates as well as FTA cards (Flinders Technology Associates cards; Whatman GE, Maidstone, UK) and discusses their use for molecular analysis, explores the technical procedures (or requirements) that can be employed to achieve adequate DNA recovery and provides an analysis of their advantages and limitations.
Differently from our previous reviews 1, 2 and although inevitable overlaps occur in some areas, the current manuscript focus on technical procedures that enable cytopathologists and cytotechnologists with the basic knowledge to make informed decisions in how to timely refer a specimen for molecular testing or outsourcing the tests.
| DIRECT SMEARS

| Technical procedures/requirements
Molecular assays have been based on the use of paraffin-embedded tissue; consequently, employing direct smears requires additional validation and refinement to fully ensure result consistency and reproducibility. 3 However, when a CB is not produced, exhausted or inadequate (lack of tumour cells), the original smears used for diagnosis become a source of neoplastic cells for mutational testing.
Tumour enrichment of direct smears can be achieved by manual microdissection, which is more easily performed than on CBs. While
CBs usually feature a pooled population of elements with a stochastic distribution of benign and neoplastic cells, the smeared sample might have a different proportion of tumour to non-neoplastic in distinct areas of the slide. 4, 5 Therefore, it becomes less problematic to find and outline areas for tumour cell enrichment on smears, even in samples with overall scant neoplastic component.
The cells for DNA extraction can be isolated from the smear either by cell scraping or by cell lifting. 6 The first method is performed by using a flat, single-edge scalpel blade to collect all material into a small cluster by scraping the blade against the slide, which is pushed to a corner-edge of the slide. The scraped, clustered material is dropped into a collection tube for subsequent nucleic acid While xylene soaking to remove the coverslip from routine smears does not affect DNA quality isolated for mutational studies, this step is time-consuming. To circumvent any delay, rapid on-site evaluation (ROSE), at the time of the FNA sampling, allows for optimal specimen triage for both microscopic diagnosis and for supplementary studies; in particular, a representative smear can be kept without the coverslip and dedicated to immediate DNA extraction. 13 In this setting, the freezer method 14 might be useful when mutational assays are carried out on stained smears, as it can speed up the process of coverslip removal. 15 With this method, once the slide is frozen, a blade is used to lift off the coverslip and after xylene soaking, the slide can then be sent for manual microdissection.
When the vast majority of the neoplastic cells are present on a single smear, the use of this slide for mutational assays may carry medico-legal consequences. To mitigate the medico legal constraints, smears can be digitally scanned prior to molecular analysis, to record the evidence of representative neoplastic microscopic fields for the archives, preferably using z-stack whole slide imaging.
3 | CP
CP can be routinely prepared from a variety of cytological specimens using a pre-defined volume. Given that they are widely used for cytomorphological analysis, it seems just natural that they could also be used for ancillary studies, mainly molecular tests. The protocols used for DNA extraction from the slides are similar and comparable to those used for smears, and can be performed on stained and unstained slides. Two protocols for cell collection from the CP slides have been compared with scalpel-blade scraping providing higher DNA yield than the cell lifting. 6 With regard to the type of glass slides that improve DNA extraction, one might consider the use of non-frosted slides, which seem to yield more DNA than specimens prepared on fully frosted slides. 6 As previously reported, for DNA extraction tissue lysis buffer is applied to the surface of the slide. This step makes it easier for the cells to be scraped, forming a sticky material that adheres to the sterile blade and is transferred to a collection tube. The scraped material undergoes cell lysis and subsequent DNA isolation. at low temperatures, which guarantees good quality DNA for many years. In a study using high-throughput multiplex mutation analysis by Mass ARRAY spectrometry, successful analysis was possible in 88% of the material harvested from unstained CP of lymphomas kept at -20°C for up to 6 years. 16 Due to their high cellularity and minimal interference from fixatives, the DNA is usually of higher quality than that harvested from CBs 6 and it could be potentially used in novel technologies such as next-generation sequencing. By contrast, despite their low employment in polymerase chain reaction (PCR)-based methodologies, CP have been used for performing fluorescence in situ hybridisation (FISH). CP are optimal for such technique, since there is minimal nuclear truncation and with cells concentrated in a small area the analysis is faster. 18 In fact, a FISH analysis study using CP for subtyping of non-Hodgkin lymphomas reported successful assay results in up to 95% of samples. These can therefore be used in a wide spectrum of scenarios, from fluids to FNA and EBUS-TBNA samples. [19] [20] [21] The use of CP for FISH has also been reported for the detection of the anaplastic lymphoma kinase (ALK) rearrangements in lung cancer specimens 22 and for the diagnosis of high grade urothelial carcinoma in voided urine specimens, using commercially available probe kits. 23 Lastly, they can also serve as a morphological surrogate of FTA cards, since a CP can be easily produced at the same time the material is placed on the cards, and can therefore help minimise the potential downsides of FTA card use. 24 The main limitation for extensive use of CP as a source of molecular analysis is the need for further standardisation and validation. More studies using this preparation for novel molecular platforms are warranted for a wider and steadier implementation of these specimens in everyday routine molecular practice.
4 | LBC
ROSE is crucial in ensuring adequacy for microscopy and mutational assays. Regrettably, owing to economical and staff limitations, ROSE is not always possible 25 and LBC stands as a valid alternative to conventional smears, limiting sampling artefacts, 26 since, after collection, the sample is completely expelled in an alcohol-based preserving solution, such as CytoLyt (Hologic, Bedford, MA, USA) or CytoRich Red (Fisher Scientific UK Ltd, Loughborough, Leicestershire, UK) and a cell monolayer slide is then prepared.
26
DNA can be extracted from LBC specimens either by scraping off cells from the slides or directly from the preserving solution.
27,28
A recent study described that cytopathologists more often outsource monolayer slides rather than vials with the cytology material in preserving solution for testing. Vial dispatching is not practical since the vial can be stored only for a short period, with limited long-term DNA stability; moreover, the residual solution is usually not sufficient for testing. 26 In addition, when the DNA is extracted from the cells after their microscopic visualisation, the mutation frequency can be correlated to the percentage of neoplastic cells. 27 
| Advantages and limitations
In our practice, smears are more cellular and yield higher quantities of DNA than LBC slides; however, differences in adequacy and mutation rates between the two sample types are minimal. 26 By contrast, LBC samples processed by CytoRich Red feature inferior DNA preservation due to the presence of a small amount (less than 1%) of formaldehyde. 15 CytoLyt specimens yield optimally preserved For IHC and FISH studies, the assay findings (antibody expression and signal location, respectively) can be directly correlated with the cytomorphological features of the matched H&E stained slide.
Another advantage of using CBs is that they allow for the use of non-fluorescence-based assays such as chromogenic in situ hybridisation and silver in situ hybridisation. 36 An in situ hybridisation for EBV-encoded RNA study using CBs showed a high concordance rate with surgical specimens emphasising their usefulness for patients with exhausted tissue blocks or no histological material available. 37 Conflicting data are available regarding the cellularity of CBs for mutation analysis. Most studies have reported good results, 38, 39 with one large series describing abundant/moderate cellularity in 52.8%
of 513 CBs cases submitted to EGFR mutation analysis. 40 However, another report described no cells and sparse/borderline cellularity in half of 76 CBs. 9 In general, the cellularity of cytology preparations reflects different algorithms used for sample triage and CB preparation and might explain the difference in the results from various series. Techniques for cell enrichment such as laser capture microdissection and microdissection of single cells can be applied to
CBs to obviate the problem of low cellularity.
41,42
| Limitations
The multitude of fixatives and preparation methods for CBs might minimally affect the final H&E-stained sections obtained for routine morphological assessment. However, a few studies have demonstrated differences for the performance of some antibodies used for IHC when the samples were submitted to alcohol-based fixatives. 43, 44 The results from thrombin and formalin fixed CBs were statistically superior to the results from Cellient automated CBs on both Ventana BenchMark ULTRA and the Ventana BenchMark XT. 45 With regards to ALK and ROS1 IHC or FISH, no evidence is currently available.
Since CBs are frequently stored under the same conditions as tissue blocks, the factors that can affect molecular tests described for FFPE tissue blocks might be applicable to FFPE CBs. Higher rate of amplification failure for mutation analysis have been reported for paraffin blocks that were more than 5 years old and attributed to DNA oxidation and fragmentation. 46 For PCR-based assays, a large series of cases submitted for EGFR mutation analysis from different referring institutions has documented test failure for CBs similar to histological specimens, regardless of the type of fixative used (alcohol or formalin). 40 Successful mutation testing has been also reported from cytological samples referred from different countries, implying that variation in acquisition, preparation, and processing of tumour material due to different clinical and laboratory practices might have minimal impact on test results. 47 One study has reported mutation analysis failure for material fixed with Duboscq-Brasil and ethanol. 48 Formalin fixation has been reported to induce cross-linking of proteins, DNA fragmentation and sequencing artefacts. 49, 50, 51 Short DNA fragments (100-200 bp) have been implicated as the reason for EGFR mutation test failure using FFPE CBs. 52 The effect of formalin fixation on NGS has been also documented, 53, 54 with one series showing a detectable but negligible effect on NGS data. 53 A recent study demonstrated that many so-called low-frequency genetic variants in large public databases may be due to DNA damage and signatures of damage were found. The extent of this damage directly confounds the determination of somatic variants in these data sets. 55 The lack of adequate cellularity assessment at the time of sample collection has been emphasised as a limitation for CBs, but it can be indirectly inferred based on the cell content of corresponding smears or by gross inspection of the needle rinse. One solution for the lack of immediate assessment might be an automated cell count of the needle rinse cell suspension or effusions before CB preparation.
6 | FTA CARDS In a prospective study of FNAB samples of non-small cell lung carcinoma and lymph nodes utilised as controls, the total amount of genetic material obtained from FTA cards of non-small cell lung carcinoma cases showed that the DNA yield and quality from all the FTA cards (four discs) were comparable with those from corresponding cryopreserved cells and no statistical differences were found (unpublished data). FTA cards are suitable for other and more complex molecular applications, since it is possible to use additional punches from the same discs when larger quantities of DNA are needed.
These data are supported also by similar results on non-Hodgkin lymphoma studies. The logarithmic increase was probably due to the maximum limit of FTA cards cell absorbance. This saturation limit in cell absorbance cannot be overcome and is independent of the cell type. 57 Another limitation in the use of the FTA cards is the quality of RNA extracted. To evaluate the possibility of storing and purifying RNA from FTA cards, RNA extraction was performed from lymph node cells obtained by FNAB. All the cases were partially stored on FTA cards and partially cryopreserved. 60 No amplification was obtained when RNA extracted from FTA cards was tested by reverse transcription-PCR using a control gene composed of six genes producing 100-200-300-400-600 bp fragments. Expected PCR bands appeared in all the cryopreserved cases, but not in the corresponding FTA cards. Some studies have evaluated the possibility of storing RNA on FTA cards from viruses, mosquitoes, protozoa, trypanosomes, plasmodia, bacteria and vegetable cells. 61, 62 Just one study achieved this goal, but the quality of the RNA obtained was poor, especially when extracted after 8-12 months. 62, 63 For human samples, only two studies succeeded in extracting RNA from cells stored in FTA cards. 64, 65 In one study, the success of the procedure was probably due to the 4°C storage, or related to the type of sample (acute lymphoblastic leukaemia), which provided a large amount of RNA that compensated for the losses. 64 In the other study, RNA extracted from cells stored on FTA cards from 66 ovarian carcinoma samples proved to be stable for only 6 months. 65 The weaknesses of FTA card for RNA storage is probably due to the high RNA fragmentation.
Notwithstanding these limitations on RNA storage and cell absorbance cut-off, FTA cards remain a good alternative to store DNA of cells for molecular analyses, providing a reliable alternative to traditional methods. The relatively small amount of stored genetic material on the FTA cards is fully counterbalanced by the easy, fast, cheap, operative-friendly procedure and high quality of the DNA. 
